AS

Amlan Sabita

Active Director Director DIN 02618544
DIN 02618544 First appointment Jul 2001 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2001
Shareholding value β€’β€’β€’β€’ Premium profile

About Amlan Sabita

Data last updated:

Amlan Sabita is a Director at Juan Biotechnology Private Limited (since 2001). The company operates in Research & Development.

DIN 02618544
Primary Designation Director
Industry Research & Development
First Appointment 31 Jul 2001
Oldest Company Age 25 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Juan Biotechnology Private Limited U73100OR2001PTC006562
Director31 Jul 20012001Active

Board colleagues of Amlan Sabita

Directorship timeline

Open interactive timeline →
Juan Biotechnology Private Limited
Premium access

Shareholding and investment profile for Amlan Sabita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amlan Sabita

Amlan Sabita currently holds 1 directorship: Juan Biotechnology Private Limited (Director, since 31 Jul 2001).

Amlan Sabita was first appointed on 31 Jul 2001 as Director at Juan Biotechnology Private Limited.

The current boards of Amlan Sabita's companies include Jamini Priya (Juan Biotechnology Private Limited), Nalini Sahu (Juan Biotechnology Private Limited), Nandan Sahu (Juan Biotechnology Private Limited), Usha Kiran (Juan Biotechnology Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available